M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for bit.bio, the Cambridge-based biotech company pioneering next-generation human cell programming ...
Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.
Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...
Rapid and reliable virus detection is one of the most critical tools for controlling outbreaks, from seasonal influenza to ...
Researchers say discoveries could expand the CRISPR toolbox and lead to more efficient, rapid diagnostic tools for detecting COVID-19, influenza, and RSV.
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Cell Counting ...
A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...
A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely silence a brain receptor that pharmaceutical companies are racing to target ...
A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective compound, and carvedilol, a widely used cardiovascular medicine—to powerfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback